hat
Tranxamic asid yo itilize kòm premye liy ki pa-ormon tretman nan malfonksyònman matris dysfunctional, ak gwo senyen ki asosye ak fibrom matris. Aspè nan istolojik nan nekwoz la nan fanm trete pa asid tranaksikik pa diferan de ensidans la espontane nan tronbozi.
eng
Tranexamic acid is used as firstline non-hormonal treatment of dysfunctional uterine bleeding, and heavy bleeding associated with uterine fibroids. The histological appearance of the necrosis in women treated by tranexamic acid is no different from the spontaneous incidence of thrombosis.